{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:38:52Z","timestamp":1791833932833,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scholarship Fund of the Swiss Chemical Industry"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Myo<\/jats:italic>-inositol hexakisphosphate (IP6) is a natural product known to inhibit vascular calcification (VC), but with limited potency and low plasma exposure following bolus administration. Here we report the design of a series of inositol phosphate analogs as crystallization inhibitors, among which 4,6-di-<jats:italic>O<\/jats:italic>-(methoxy-diethyleneglycol)-<jats:italic>myo<\/jats:italic>-inositol-1,2,3,5-tetrakis(phosphate), (OEG<jats:sub>2<\/jats:sub>)<jats:sub>2<\/jats:sub>-IP4, displays increased in vitro activity, as well as more favorable pharmacokinetic and safety profiles than IP6 after subcutaneous injection. (OEG<jats:sub>2<\/jats:sub>)<jats:sub>2<\/jats:sub>-IP4 potently stabilizes calciprotein particle (CPP) growth, consistently demonstrates low micromolar activity in different in vitro models of VC (i.e., human serum, primary cell cultures, and tissue explants), and largely abolishes the development of VC in rodent models, while not causing toxicity related to serum calcium chelation. The data suggest a mechanism of action independent of the etiology of VC, whereby (OEG<jats:sub>2<\/jats:sub>)<jats:sub>2<\/jats:sub>-IP4 disrupts the nucleation and growth of pathological calcification.<\/jats:p>","DOI":"10.1038\/s41467-019-14091-4","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:03:18Z","timestamp":1580900598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers"],"prefix":"10.1038","volume":"11","author":[{"given":"Antonia E.","family":"Schantl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-433X","authenticated-orcid":false,"given":"Geert J.","family":"Behets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-0046","authenticated-orcid":false,"given":"Marc","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mordasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-1325","authenticated-orcid":false,"given":"Laurent A.","family":"Decosterd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5355-3109","authenticated-orcid":false,"given":"Mark G.","family":"MacAskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Alcaide-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A. S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Beindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Labarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrismita","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Castagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias E.","family":"Ivarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-1292","authenticated-orcid":false,"given":"Jean-Christophe","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"14091_CR1","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/circ.104.16.1881","volume":"104","author":"LL Demer","year":"2001","unstructured":"Demer, L. L. & Tintut, Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 104, 1881\u20131883 (2001).","journal-title":"Circulation"},{"key":"14091_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1138\/20080298","volume":"5","author":"DA Towler","year":"2008","unstructured":"Towler, D. A. Vascular calcification: a perspective on an imminent disease epidemic. IBMS BoneKEy 5, 41\u201358 (2008).","journal-title":"IBMS BoneKEy"},{"key":"14091_CR3","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1161\/CIRCULATIONAHA.107.749655","volume":"116","author":"CM Shanahan","year":"2007","unstructured":"Shanahan, C. M. Inflammation ushers in calcification: a cycle of damage and protection? Circulation 116, 2782\u20132785 (2007).","journal-title":"Circulation"},{"key":"14091_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","volume":"15","author":"AP Gu\u00e9rin","year":"2000","unstructured":"Gu\u00e9rin, A. P., London, G. M., Marchais, S. J. & Metivier, F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol. Dial. Transplant. 15, 1014\u20131021 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14091_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0735-1097(97)00443-9","volume":"31","author":"G Sangiorgi","year":"1998","unstructured":"Sangiorgi, G. et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol. 31, 126\u2013133 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14091_CR6","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/hc4101.097527","volume":"104","author":"K Pohle","year":"2001","unstructured":"Pohle, K. et al. Progression of aortic valve calcification. Circulation 104, 1927\u20131932 (2001).","journal-title":"Circulation"},{"key":"14091_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(87)91370-5","volume":"330","author":"ER Maher","year":"1987","unstructured":"Maher, E. R., Young, G., Smyth-Walsh, B., Pugh, S. & Curtis, J. R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 330, 875\u2013877 (1987).","journal-title":"Lancet"},{"key":"14091_CR8","doi-asserted-by":"crossref","unstructured":"Rogers, M. A. & Aikawa, E. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat. Rev. Cardiol. 16, 261\u2013274 (2018).","DOI":"10.1038\/s41569-018-0123-8"},{"key":"14091_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi, M., Towler, D. & Slatopolsky, E. Vascular calcification: the killer of patients with chronic kidney disease. J. Am. Soc. Nephrol. 20, 1453\u20131464 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14091_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"key":"14091_CR11","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder, R. et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol. Dial. Transplant. 20, 1048\u20131056 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14091_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","volume":"90","author":"Y Nitschke","year":"2012","unstructured":"Nitschke, Y. et al. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 90, 25\u201339 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"14091_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.18632\/aging.101821","volume":"11","author":"JW Bartstra","year":"2019","unstructured":"Bartstra, J. W., De Jong, P. A. & Spiering, W. Accelerated peripheral vascular aging in pseudoxanthoma elasticum\u2014proof of concept for arterial calcification\u2014induced cardiovascular disease. Aging 11, 1062\u20131064 (2019).","journal-title":"Aging"},{"key":"14091_CR14","doi-asserted-by":"publisher","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","volume":"272","author":"W Jahnen-Dechent","year":"1997","unstructured":"Jahnen-Dechent, W. et al. Cloning and targeted deletion of the mouse fetuin gene. J. Biol. Chem. 272, 31496\u201331503 (1997).","journal-title":"J. Biol. Chem."},{"key":"14091_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78\u201381 (1997).","journal-title":"Nature"},{"key":"14091_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/195911a0","volume":"195","author":"H Fleisch","year":"1962","unstructured":"Fleisch, H. & Bisaz, S. Mechanism of calcification: inhibitory role of pyrophosphate. Nature 195, 911 (1962).","journal-title":"Nature"},{"key":"14091_CR17","first-page":"1","volume":"2","author":"AE Schantl","year":"2018","unstructured":"Schantl, A. E., Ivarsson, M. E. & Leroux, J.-C. Investigational pharmacological treatments for vascular calcification. Adv. Ther. 2, 1\u201316 (2018).","journal-title":"Adv. Ther."},{"key":"14091_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMra0912522","volume":"362","author":"M Tonelli","year":"2010","unstructured":"Tonelli, M., Pannu, N. & Manns, B. Oral phosphate binders in patients with kidney failure. N. Engl. J. Med. 362, 1312\u20131324 (2010).","journal-title":"N. Engl. J. Med."},{"key":"14091_CR19","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M709938200","volume":"283","author":"A Heiss","year":"2008","unstructured":"Heiss, A. et al. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 283, 14815\u201314825 (2008).","journal-title":"J. Biol. Chem."},{"key":"14091_CR20","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1039\/c0sm01191f","volume":"7","author":"J Wald","year":"2011","unstructured":"Wald, J. et al. Formation and stability kinetics of calcium phosphate\u2013fetuin-A colloidal particles probed by time-resolved dynamic light scattering. Soft Matter 7, 2869\u20132874 (2011).","journal-title":"Soft Matter"},{"key":"14091_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","volume":"111","author":"M Herrmann","year":"2012","unstructured":"Herrmann, M. et al. Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A. Circ. Res. 111, 575\u2013584 (2012).","journal-title":"Circ. Res."},{"key":"14091_CR22","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch, A. et al. Nanoparticle-based test measures overall propensity for calcification in serum. J. Am. Soc. Nephrol. 23, 1744\u20131752 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14091_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrneph.2013.111","volume":"9","author":"M Kuro-o","year":"2013","unstructured":"Kuro-o, M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat. Rev. Nephrol. 9, 650\u2013660 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"14091_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01991","volume":"9","author":"S K\u00f6ppert","year":"2018","unstructured":"K\u00f6ppert, S. et al. Cellular clearance and biological activity of calciprotein particles depend on their maturation state and crystallinity. Front. Immunol. 9, 1\u201317 (2018).","journal-title":"Front. Immunol."},{"key":"14091_CR25","first-page":"1","volume":"34","author":"M Kuro-o","year":"2014","unstructured":"Kuro-o, M. Calciprotein particle (CPP): a true culprit of phosphorus woes? Nefrologia 34, 1\u20134 (2014).","journal-title":"Nefrologia"},{"key":"14091_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19677-4","volume":"8","author":"Y Miura","year":"2018","unstructured":"Miura, Y. et al. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci. Rep. 8, 1256 (2018).","journal-title":"Sci. Rep."},{"key":"14091_CR27","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","volume":"27","author":"ER Smith","year":"2012","unstructured":"Smith, E. R. et al. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol. Dial. Transplant. 27, 1957\u20131966 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14091_CR28","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.2009090944","volume":"21","author":"T Hamano","year":"2010","unstructured":"Hamano, T. et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J. Am. Soc. Nephrol. 21, 1998\u20132007 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14091_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/ndt\/gfy117","volume":"34","author":"W Chen","year":"2019","unstructured":"Chen, W. et al. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles. Nephrol. Dial. Transplant. 34, 992\u20131000 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14091_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh, P. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-\u03b1. Atherosclerosis 251, 404\u2013414 (2016).","journal-title":"Atherosclerosis"},{"key":"14091_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nmat3627","volume":"12","author":"S Bertazzo","year":"2013","unstructured":"Bertazzo, S. et al. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat. Mater. 12, 576\u2013583 (2013).","journal-title":"Nat. Mater."},{"key":"14091_CR32","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/natrevmats.2016.41","volume":"1","author":"N Reznikov","year":"2016","unstructured":"Reznikov, N., Steele, J. A. M., Fratzl, P. & Stevens, M. M. A materials science vision of extracellular matrix mineralization. Nat. Rev. Mater. 1, 16041 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"14091_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","volume":"383","author":"NV Joshi","year":"2014","unstructured":"Joshi, N. V. et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383, 705\u2013713 (2014).","journal-title":"Lancet"},{"key":"14091_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8495","volume":"6","author":"A Irkle","year":"2015","unstructured":"Irkle, A. et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat. Commun. 6, 7495 (2015).","journal-title":"Nat. Commun."},{"key":"14091_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jcmg.2017.03.005","volume":"10","author":"T Nakahara","year":"2017","unstructured":"Nakahara, T. et al. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc. Imaging 10, 582\u2013593 (2017).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"14091_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","volume":"2","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2, 635\u2013643 (2017).","journal-title":"JAMA Cardiol."},{"key":"14091_CR37","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London, G. M. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731\u20131740 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14091_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000294405","volume":"31","author":"RS Shantouf","year":"2010","unstructured":"Shantouf, R. S. et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am. J. Nephrol. 31, 419\u2013425 (2010).","journal-title":"Am. J. Nephrol."},{"key":"14091_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/35073015","volume":"2","author":"RF Irvine","year":"2001","unstructured":"Irvine, R. F. & Schell, M. J. Back in the water: the return of the inositol phosphates. Nat. Rev. Mol. Cell Biol. 2, 327\u2013338 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"14091_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2741\/1786","volume":"11","author":"F Grases","year":"2006","unstructured":"Grases, F. et al. Phytate (myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front. Biosci. 11, 136\u2013142 (2006).","journal-title":"Front. Biosci."},{"key":"14091_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/cs0430377","volume":"43","author":"CJ Van den Berg","year":"1972","unstructured":"Van den Berg, C. J., Hill, L. F. & Stanbury, S. W. Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat. Clin. Sci. 43, 377\u2013383 (1972).","journal-title":"Clin. Sci."},{"key":"14091_CR42","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40620-019-00631-0","volume":"32","author":"VM Brandenburg","year":"2019","unstructured":"Brandenburg, V. M. et al. Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J. Nephrol. 32, 811\u2013821 (2019).","journal-title":"J. Nephrol."},{"key":"14091_CR43","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/bcp.13752","volume":"84","author":"J Perell\u00f3","year":"2018","unstructured":"Perell\u00f3, J. et al. First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification. Br. J. Clin. Pharmacol. 84, 2867\u20132876 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"14091_CR44","doi-asserted-by":"publisher","unstructured":"Raggi, P. et al. Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized, phase 2b study. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044195 (2019).","DOI":"10.1161\/CIRCULATIONAHA.119.044195"},{"key":"14091_CR45","first-page":"1","volume":"13","author":"MD Ferrer","year":"2018","unstructured":"Ferrer, M. D. et al. Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification. PLoS ONE 13, 1\u201319 (2018).","journal-title":"PLoS ONE"},{"key":"14091_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40620-018-0471-9","volume":"31","author":"J Perell\u00f3","year":"2018","unstructured":"Perell\u00f3, J. et al. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels. J. Nephrol. 31, 287\u2013296 (2018).","journal-title":"J. Nephrol."},{"key":"14091_CR47","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1021\/acsami.6b15925","volume":"9","author":"X Huang","year":"2017","unstructured":"Huang, X. et al. Characterization of calcium phosphate nanoparticles based on a PEGylated chelator for gene delivery. ACS Appl. Mater. Interfaces 9, 10435\u201310445 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"14091_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/adhm.201200088","volume":"2","author":"EV Giger","year":"2013","unstructured":"Giger, E. V., Castagner, B., R\u00e4ikk\u00f6nen, J., M\u00f6nkk\u00f6nen, J. & Leroux, J. C. siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators. Adv. Healthc. Mater. 2, 134\u2013144 (2013).","journal-title":"Adv. Healthc. Mater."},{"key":"14091_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"I Ekladious","year":"2018","unstructured":"Ekladious, I., Colson, Y. L. & Grinstaff, M. W. Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat. Rev. Drug Discov. 18, 273\u2013294 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"14091_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000462984","volume":"7","author":"A Verhulst","year":"2017","unstructured":"Verhulst, A., Neven, E. & D\u2019Haese, P. C. Characterization of an animal model to study risk factors and new therapies for the cardiorenal syndrome, a major health issue in our aging population. Cardiorenal Med. 7, 234\u2013244 (2017).","journal-title":"Cardiorenal Med."},{"key":"14091_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chembiol.2018.10.002","volume":"26","author":"ME Ivarsson","year":"2019","unstructured":"Ivarsson, M. E. et al. Small-molecule allosteric triggers of clostridium difficile toxin B auto-proteolysis as a therapeutic strategy. Cell Chem. Biol. 26, 17\u201326 (2019).","journal-title":"Cell Chem. Biol."},{"key":"14091_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2018.02.023","volume":"110","author":"ER Smith","year":"2018","unstructured":"Smith, E. R., Hewitson, T. D., Hanssen, E. & Holt, S. G. Biochemical transformation of calciprotein particles in uraemia. Bone 110, 355\u2013367 (2018).","journal-title":"Bone"},{"key":"14091_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.22203\/eCM.v001a04","volume":"41","author":"E Suvorova","year":"2001","unstructured":"Suvorova, E. & Buffat, P. Electron diffraction and high resolution transmission electron microscopy in the characterization of calcium phosphate precipitation from aqueous solutions under biomineralization conditions. Eur. Cells Mater. 41, 27\u201342 (2001).","journal-title":"Eur. Cells Mater."},{"key":"14091_CR54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jacc.2017.11.053","volume":"71","author":"RO Forsythe","year":"2018","unstructured":"Forsythe, R. O. et al. 18F-sodium fluoride uptake in abdominal aortic aneurysms: The SoFIA3 Study. J. Am. Coll. Cardiol. 71, 513\u2013523 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14091_CR55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5527\/wjn.v5.i5.398","volume":"5","author":"UAA Sharaf El Din","year":"2016","unstructured":"Sharaf El Din, U. A. A., Salem, M. M. & Abdulazim, D. O. Vascular calcification: when should we interfere in chronic kidney disease patients and how? World J. Nephrol. 5, 398\u2013417 (2016).","journal-title":"World J. Nephrol."},{"key":"14091_CR56","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"JL Reynolds","year":"2004","unstructured":"Reynolds, J. L. et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 15, 2857\u20132867 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14091_CR57","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1161\/CIRCRESAHA.116.305012","volume":"116","author":"AN Kapustin","year":"2015","unstructured":"Kapustin, A. N. et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ. Res. 116, 1312\u20131323 (2015).","journal-title":"Circ. Res."},{"key":"14091_CR58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-2796.2006.01692.x","volume":"260","author":"VP Iyemere","year":"2006","unstructured":"Iyemere, V. P., Proudfoot, D., Weissberg, P. L. & Shanahan, C. M. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J. Intern. Med. 260, 192\u2013210 (2006).","journal-title":"J. Intern. Med."},{"key":"14091_CR59","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneph.2013.176","volume":"9","author":"CM Shanahan","year":"2013","unstructured":"Shanahan, C. M. Mechanisms of vascular calcification in CKD - Evidence for premature ageing? Nat. Rev. Nephrol. 9, 661\u2013670 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"14091_CR60","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ki.2011.59","volume":"79","author":"EG Neven","year":"2011","unstructured":"Neven, E. G., De Schutter, T. M., De Broe, M. E. & D\u2019Haese, P. C. Cell biological and physicochemical aspects of arterial calcification. Kidney Int. 79, 1166\u20131177 (2011).","journal-title":"Kidney Int."},{"key":"14091_CR61","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00223-017-0313-0","volume":"101","author":"MMX Cai","year":"2017","unstructured":"Cai, M. M. X., Smith, E. R., Tan, S. J., Hewitson, T. D. & Holt, S. G. The role of secondary calciprotein particles in the mineralisation paradox of chronic kidney disease. Calcif. Tissue Int. 101, 570\u2013580 (2017).","journal-title":"Calcif. Tissue Int."},{"key":"14091_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2017.08.012","volume":"265","author":"P Aghagolzadeh","year":"2017","unstructured":"Aghagolzadeh, P. et al. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1\/NRF2\/NQO1 activation. Atherosclerosis 265, 78\u201386 (2017).","journal-title":"Atherosclerosis"},{"key":"14091_CR63","doi-asserted-by":"publisher","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","volume":"8","author":"ER Smith","year":"2013","unstructured":"Smith, E. R., Hanssen, E., McMahon, L. P. & Holt, S. G. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS ONE 8, e60904 (2013).","journal-title":"PLoS ONE"},{"key":"14091_CR64","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ki.2011.212","volume":"80","author":"E Zavaczki","year":"2011","unstructured":"Zavaczki, E. et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 80, 731\u2013739 (2011).","journal-title":"Kidney Int."},{"key":"14091_CR65","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.metabol.2011.02.015","volume":"60","author":"J Eiseman","year":"2011","unstructured":"Eiseman, J., Lan, J., Guo, J., Joseph, E. & Vucenik, I. Pharmacokinetics and tissue distribution of inositol hexaphosphate in C.B17 SCID mice bearing human breast cancer xenografts. Metabolism 60, 1465\u20131474 (2011).","journal-title":"Metabolism"},{"key":"14091_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ki.2013.34","volume":"83","author":"TM De Schutter","year":"2013","unstructured":"De Schutter, T. M. et al. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int. 83, 1109\u20131117 (2013).","journal-title":"Kidney Int."},{"key":"14091_CR67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcmg.2015.02.006","volume":"8","author":"HS Hecht","year":"2015","unstructured":"Hecht, H. S. Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc. Imag. 8, 579\u2013596 (2015).","journal-title":"JACC Cardiovasc. Imag."},{"key":"14091_CR68","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2004070610","volume":"16","author":"H Kramer","year":"2005","unstructured":"Kramer, H., Toto, R., Peshock, R., Cooper, R. & Victor, R. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J. Am. Soc. Nephrol. 16, 507\u2013513 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14091_CR69","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","volume":"7","author":"MR Dweck","year":"2014","unstructured":"Dweck, M. R. et al. 18F-Sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ. Cardiovasc. Imaging 7, 371\u2013378 (2014).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"14091_CR70","doi-asserted-by":"crossref","first-page":"24871","DOI":"10.1016\/S0021-9258(18)35844-7","volume":"267","author":"Y Chen","year":"1992","unstructured":"Chen, Y., Bal, B. S. & Gorski, J. P. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J. Biol. Chem. 267, 24871\u201324878 (1992).","journal-title":"J. Biol. Chem."},{"key":"14091_CR71","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1074\/jbc.M210868200","volume":"278","author":"A Heiss","year":"2003","unstructured":"Heiss, A. et al. Structural basis of calcification inhibition by \u03b12-HS glycoprotein\/fetuin-A: formation of colloidal calciprotein particles. J. Biol. Chem. 278, 13333\u201313341 (2003).","journal-title":"J. Biol. Chem."},{"key":"14091_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05474-y","volume":"7","author":"ER Smith","year":"2017","unstructured":"Smith, E. R., Hewitson, T. D., Cai, M. M. X. & Aghagolzadeh, P. A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum. Sci. Rep. 7, 5686 (2017).","journal-title":"Sci. Rep."},{"key":"14091_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.114.217208","volume":"351","author":"G Mattheolabakis","year":"2014","unstructured":"Mattheolabakis, G. et al. Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-ibuprofen. J. Pharmacol. Exp. Ther. 351, 61\u201366 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"14091_CR74","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/jbmr.2585","volume":"30","author":"E Neven","year":"2015","unstructured":"Neven, E. et al. Disturbances in bone largely predict aortic calcification in an alternative rat model developed to study both aascular and bone pathology in chronic kidney disease. J. Bone Miner. Res. 30, 2313\u20132324 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"14091_CR75","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","volume":"91","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel, P., Behets, G. J., Viaene, L. & D\u2019Haese, P. C. Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney Int. 91, 469\u2013476 (2017).","journal-title":"Kidney Int."},{"key":"14091_CR76","unstructured":"Ivarsson, M. M., Castagner, B., Leroux, J. J.-C. & Pasch, A. Inositol derivatives for use in pathological crystallization. Int. Pat. Appl. WO 2017\/098047 A1 (2019)."},{"key":"14091_CR77","unstructured":"Castagner, B., Leroux, J.-C., Ivarsson, M., Schneider, G. & Pratsinis, A. Pharmaceutical compounds for use in the therapy of clostridium difficile infection. US Pat. 9751903 B2 (2017)."},{"key":"14091_CR78","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bbrc.2010.06.024","volume":"397","author":"AJ Oakley","year":"2010","unstructured":"Oakley, A. J. The structure of Aspergillus niger phytase PhyA in complex with a phytate mimetic. Biochem. Biophys. Res. Commun. 397, 745\u2013749 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14091_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ab.2005.10.008","volume":"348","author":"EHS Sousa","year":"2006","unstructured":"Sousa, E. H. S., Garay, P. A., Tinianow, J. N. & Gerber, N. C. Development of a spectrophotometric assay for cyclase activity. Anal. Biochem. 348, 57\u201363 (2006).","journal-title":"Anal. Biochem."},{"key":"14091_CR80","unstructured":"Shanahan, C. M. & Proudfoot, D. Human Vascular Smooth Muscle Cell Culture. in Human Cell Culture Protocols (eds Mitry, R. & Hughes R.) Vol. 806, 301\u2013336 (Humana Press, 2012)."},{"key":"14091_CR81","unstructured":"Kelynack, K. J. & Holt, S. G. An In Vitro Murine Model of Vascular Smooth Muscle Cell Mineralization. in Kidney Research: Experimental Protocols\u00a0(eds Hewitson, T. D., Smith, E. R. & Holt, S. G.) Vol. 466, 193\u2013203 (Humana Press, 2016)."},{"key":"14091_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault, M., Preston, J. A., Marriott, H. M., Whyte, M. K. B. & Dockrell, D. H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5, 1\u201310 (2010).","journal-title":"PLoS ONE"},{"key":"14091_CR83","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Huo, M., Zhou, J. & Xie, S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Prog. Biomed. 99, 306\u2013314 (2010).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"14091_CR84","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","volume":"112","author":"O Phan","year":"2005","unstructured":"Phan, O. et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 112, 2875\u20132882 (2005).","journal-title":"Circulation"},{"key":"14091_CR85","first-page":"391","volume":"10","author":"M Jaffe","year":"1886","unstructured":"Jaffe, M. Ueber den niederschlag, welchen pikrins\u00e4ure in normalem harn erzeugt und \u00fcber eine neue reaction des kreatinins. Z. Physiol. Chem. 10, 391\u2013400 (1886).","journal-title":"Z. Physiol. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14091-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:54:36Z","timestamp":1670262876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14091"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-14091-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.I., J.C.L., and B.C. are co-inventors of patents licensed to Inositec Inc. and shareholders thereof. Inositec\u2019s lead compound INS-3001 ((OEG<sub>2<\/sub>)<sub>2<\/sub>-IP4) is in development for the prevention and treatment of diseases driven by cardiovascular calcification. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"721"}}